@article{108749a3eab24384a697dcd44fd5485d,
title = "Developing a Novel Prognostic Model to Predict Overall Survival (OS) and 90 Day Mortality Rate (90DM) for Metastatic Colorectal Cancer (mCRC) Patients in Phase I Trials",
author = "Santiago Aparo and Gopichand Pendurti and Shah, \{Umang H.\} and Umang Swami and Yijuan Hou and Ghalib, \{Mohammad Haroon\} and Imran Chaudhary",
note = "e14618 Background: Phase I trials are a critical component of drug development. It is vital to select patients who are most likely to benefit. Prognostic scores like Royal Marsden hospital (RMH), Prince Margaret hospital index (PMHI), Hammersmith score (HS) use low albumin (alb), high LDH, > 2 metastatic sites, ECOG PS, and low sodium to predict the 90DM and OS on trials.",
year = "2015",
language = "American English",
volume = "33",
journal = "Journal of Clinical Oncology / American Society of Clinical Oncology (ASCO) Annual Meeting",
}